Your Drug Needs a Device Patent to Survive: The MedTech Crossover Strategy
The next billion-dollar drug may not be protected by a better molecule. It may be protected by the device that delivers it.
For decades, pharmaceutical companies have treated drug patents as the center of their commercial defense: composition of matter…
Your Drug Needs a Device Patent to Survive: The MedTech Crossover Strategy Read Post »